−0.050AUD
−4.70 MAUD
27.14 MAUD
42.43 M
About CYCLOPHARM LIMITED
Sector
Industry
CEO
James M. McBrayer
Website
Headquarters
Kingsgrove
Employees (FY)
87
Founded
2005
ISIN
AU000000CYC5
FIGI
BBG000QFS060
Cyclopharm Ltd. is a radiopharmaceutical company, which engages in diagnostic imaging in lung health. It manufactures and sells medical devices and pharmaceutical products. It operates through Technegas and Molecular Imaging segments. The Technegas segment supplies diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The company was founded in 1984 and is headquartered in Kingsgrove, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CYC is 1.780 AUD — it has decreased by 1.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CYCLOPHARM LIMITED stocks are traded under the ticker CYC.
CYCLOPHARM LIMITED is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
CYC stock is 1.12% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is CYCLOPHARM LIMITED there?
One year price forecast for CYCLOPHARM LIMITED has a max estimate of 3.800 AUD and a min estimate of 3.800 AUD.
CYCLOPHARM LIMITED revenue for the last quarter amounts to 16.49 M AUD despite the estimated figure of 15.30 M AUD. In the next quarter revenue is expected to reach 13.10 M AUD.
Yes, you can track CYCLOPHARM LIMITED financials in yearly and quarterly reports right on TradingView.
CYC stock has fallen by 1.66% compared to the previous week, the month change is a 0.84% fall, over the last year CYCLOPHARM LIMITED has showed a 16.43% decrease.
CYC net income for the last quarter is −1.81 M AUD, while the quarter before that showed −2.90 M AUD of net income which accounts for 37.64% change. Track more CYCLOPHARM LIMITED financial stats to get the full picture.
Today CYCLOPHARM LIMITED has the market capitalization of 169.54 M, it has increased by 0.10% over the last week.
Like other stocks, CYC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYCLOPHARM LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 87.00 employees. See our rating of the largest employees — is CYCLOPHARM LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYCLOPHARM LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYCLOPHARM LIMITED stock shows the neutral signal. See more of CYCLOPHARM LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CYCLOPHARM LIMITED future price: according to them, CYC price has a max estimate of 3.80 AUD and a min estimate of 3.80 AUD. Read a more detailed CYCLOPHARM LIMITED forecast: see what analysts think of CYCLOPHARM LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CYCLOPHARM LIMITED EBITDA is −8.74 M AUD, and current EBITDA margin is −29.27%. See more stats in CYCLOPHARM LIMITED financial statements.